NEWS

We inform you about the current business development of HAEMATO AG and about our investor relations activities.

HAEMATO AG acquires “M1 Aesthetics GmbH” from M1 Kliniken AG – Contribution of the company within the scope of a capital increase in kind of HAEMATO AG

HAEMATO AG acquires “M1 Aesthetics GmbH” from M1 Kliniken AG – Contribution of the company within the scope of a capital increase in kind of HAEMATO AG

Berlin, 15.12.2020 – M1 Kliniken AG and HAEMATO AG today signed a contract for the acqui-sition of all shares in M1 Aesthetics GmbH by HAEMATO AG. M1 Kliniken AG will contribute M1 Aesthetics GmbH to HAEMATO AG within the scope of a capital increase through contri-bution in kind. For this purpose, the Management Board of HAEMATO AG decided today with the approval of the Supervisory Board to increase the company’s share capital by EUR 2,467,201 to EUR 4,753,916 by issuing 2,467,201 new shares of HAEMATO AG through a ca-pital increase against contribution in kind under exclusion of the subscription right of the shareholders by using the existing authorised capital. The new shares will be subscribed and taken over exclusively by M1 Kliniken AG. The transaction will be implemented with effect from 1.1.2021. After completion of the transaction, M1 Kliniken AG will hold a total of 75.8% of the share capital of HAEMATO AG.

read more

HAEMATO AG: Expansion of the board of directors: Strengthening the strategic and operative implementation of the product business in the Haemato Group Schönefeld, 30.11.2020 - The supervisory board of HAEMATO AG has appointed Mr. Patrick Brenske to the board of...

read more
Ad-hoc disclosure under Art.17 MAR

Ad-hoc disclosure under Art.17 MAR

HAEMATO AG: Ad-hoc disclosure under Article 17 MAR HAEMATO AG: MPH Health Care AG brings its shares in HAEMATO AG to M1 Kliniken AG as part of a non-cash capital increase. Today MPH Health Care AG and M1 Kliniken AG informed us that MPH Health Care AG transfers all of...

read more
appropriation of profits

appropriation of profits

The Supervisory Board of HAEMATO AG (ISIN: DE0006190705) approved today’s proposal for the appropriation of profits by the Management Board in today’s balance sheet meeting. Accordingly, the management of the Annual General Meeting on July 8, 2020 will propose that the retained earnings for the 2019 financial year be carried forward to new account.

read more
Ad-Hoc-News from 07.07.2017

Ad-Hoc-News from 07.07.2017

In today's meeting, the Supervisory Board of HAEMATO AG ("HAEMATO" or the "Company") accepted the wish of Dr. Christian Pahl to not extend his contract as Management Board Member beyond the current term ending 31 July 2017. The Supervisory Board regrets...

read more

HAEMATO AG

HAEMATO AG
Lilienthalstraße 5c
12529 Schönefeld
Germany

Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79
E-Mail: info@haemato.ag